Effects of the vasodilating drugs (Diazoxide and Epidrazine) on the central and peripheral circulation.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 891213)

Published in Contrib Nephrol on January 01, 1977

Authors

J Bahlmann, J Brod, M Cachovan, H Dahlgrün

Articles by these authors

The rational basis of diagnosis in internal medicine. J R Coll Physicians Lond (1977) 2.58

Guidelines for therapeutic studies on peripheral arterial occlusive disease in Fontaine stages II-IV. German society of Angiology. Vasa (1992) 1.51

Pathogenesis of cardiac oedema. Br Med J (1972) 1.44

Guidelines for therapeutic studies in Fontaine's stages II-IV peripheral arterial occlusive disease. German Society of Angiology. Vasa (1995) 1.40

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension. Br J Clin Pharmacol (1979) 1.10

The effect on urinary sodium excretion of blood volume expansion without changing the composition of blood in the dog. Clin Sci (1967) 1.03

The effect on urinary sodium excretion of altering the packed cell volume with albumin solutions without changing the blood volume in the dog. Clin Sci (1967) 1.01

Effect of diazoxide on capacitance vessels. Eur J Clin Pharmacol (1978) 1.00

Haemodynamics of hypertension in chronic renal disease. Contrib Nephrol (1977) 0.99

[The capacity system in hypertension]. Verh Dtsch Ges Inn Med (1974) 0.96

Acute effects of clonidine on central and peripheral haemodynamics and plasma renin activity. Eur J Clin Pharmacol (1972) 0.92

Comparison of haemodynamic effects of equipressor doses of intravenous angiotensin and noradrenaline in man. Clin Sci (1969) 0.89

Lymph node involvement in renal cell carcinoma and survival chance by systematic lymphadenectomy. Anticancer Res (1999) 0.86

Mechanisms for the elevation of blood pressure in human renal disease. Preliminary report. Hypertension (1983) 0.83

Treatment of patients with peripheral arterial occlusive disease Fontaine stage IV with intravenous iloprost and PGE1: a randomized open controlled study. Prostaglandins Leukot Essent Fatty Acids (1993) 0.83

Development of hypertension in renal disease. Clin Sci (Lond) (1983) 0.81

Investigations on the Na+, K+-pump in erythrocytes of patients with renal hypertension. Clin Sci (Lond) (1984) 0.81

Haemodynamic response to an acute emotional stress (mental arithmetic) with special reference to the venous side. Aust N Z J Med (1976) 0.81

[On the glucose and lactate metabolism of isolated dog kidneys]. Pflugers Arch Gesamte Physiol Menschen Tiere (1965) 0.80

The measurement of the renal venous outflow in man by the local thermodilution method. Nephron (1971) 0.80

[Changes in segmental pulse wave velocity in arteriosclerosis]. Verh Dtsch Ges Kreislaufforsch (1974) 0.79

[Effect of emotional stress (mental arithmetics) on venous circulation]. Vnitr Lek (1970) 0.79

Skin microcirculation and regional peripheral resistance in patients with chronic renal anaemia treated with recombinant human erythropoietin. Eur J Clin Invest (1990) 0.79

Study of renal function in the differential diagnosis of kidney disease. Br Med J (1971) 0.79

Effect of treatment with recombinant human erythropoietin on peripheral hemodynamics and oxygenation. Contrib Nephrol (1988) 0.79

Forearm vessels in hypertension of chronic renal disease. Contrib Nephrol (1982) 0.78

Central and peripheral circulation after an isotonic volume expansion with saline in human subjects. Contrib Nephrol (1980) 0.78

Results of a prospective study of toxemia of pregnancy. Contrib Nephrol (1981) 0.78

[Quality of life in peripheral arterial occlusive disease. Multicenter study of quality of life characteristics with a newly developed disease-specific questionnaire]. Med Klin (Munich) (1995) 0.78

Long-term effects of treatment with recombinant human erythropoietin on haemodynamics and tissue oxygenation in patients with renal anaemia. Nephrol Dial Transplant (1990) 0.78

Effect of the angiotensin antagonist saralasin on hemodynamics in hypertensive non-uraemic chronic renal disease. Nephron (1980) 0.78

Micropuncture study of isolated perfused rat kidney. Am J Physiol (1967) 0.77

[Studies on the pituitary-testicular axis in male patients with chronic renal failure with different glomerular filtration rate (author's transl)]. Klin Wochenschr (1976) 0.77

Arterial hypertension in adults after surgical treatment of aortic coarctation. Thorac Cardiovasc Surg (1998) 0.77

Effects of aging on the glomerular capillaries, blood pressure, and renal function in rats. Contrib Nephrol (1982) 0.77

Pharmacokinetics of pantoprazole in patients with end-stage renal failure. Nephrol Dial Transplant (1998) 0.76

Migration of the uncemented Harris-Galante acetabular cup: results of the einbildroentgenanalyse (EBRA) method. J Arthroplasty (1997) 0.76

Complement activation during hemodialysis. Comparison of polysulfone and cuprophan membranes. Contrib Nephrol (1985) 0.76

Improvement in the quality of life after i.v. PGE1 therapy for intermittent claudication. Vasa (1997) 0.76

Green College lectures: 1984. Medicine in eastern Europe. Br Med J (Clin Res Ed) (1984) 0.75

[Comparison of postmortem angiograms with macro and microscopic findings on the A. femoralis and A. poplitea]. Arch Kreislaufforsch (1967) 0.75

Volume homeostasis, renal function and hypertension. Ulster Med J (1985) 0.75

Chronic renal parenchymal disease and hypertension. Kidney Int Suppl (1975) 0.75

Muscle blood flow in heart failure. Kardiol Pol (1968) 0.75

Effect of an alpha- and beta-adrenoceptor-blocking agent (labetalol) on haemodynamics in hypertension. Br J Clin Pharmacol (1979) 0.75

Conventional methods for renal clearance measurement used in man. Contrib Nephrol (1978) 0.75

Nephrologist's thoughts on toxaemia of pregnancy. Panminerva Med (1978) 0.75

The history of medicine at Charles University. J R Coll Physicians Lond (1982) 0.75

General and regional hemodynamics in hypertension in chronic renal disease. Clin Nephrol (1975) 0.75

Nephrology in the past, in the present and perspectives in the future. Minerva Nefrol (1983) 0.75

[Nephrologic aspects of late gestosis (author's transl)]. Z Geburtshilfe Perinatol (1974) 0.75

[Differential diagnosis of proteinuria]. Dtsch Med J (1969) 0.75

Environmental stress and hypertension. Introduction. Contrib Nephrol (1982) 0.75

[Kidney in heart failure (author's transl)]. Klin Wochenschr (1975) 0.75

Central and peripheral haemodynamic effects of angiotensin. Contrib Nephrol (1977) 0.75

Effect of correction of anemia on the glomerular filtration rate in chronic renal failure. Isr J Med Sci (1967) 0.75

[Back to human medicine]. Ther Ggw (1981) 0.75

Clinical and haemodynamic study of a new vasodilator drug L6150 (3-[bis-(2-hydroxyethyl)amino]-6-hydrazinopyridazine) in man. Clin Sci Mol Med Suppl (1976) 0.75

[Water and potassium metabolism changes]. Minerva Med (1976) 0.75

Phenacetin abuse and chronic pyelonephritis. Nephron (1977) 0.75

Renal hypertension I. Foreword. Clin Nephrol (1975) 0.75

[Pathogenesis of hypertension]. Krankenpfl J (1981) 0.75

Haemodynamics and emotional stress. Bibl Psychiatr (1970) 0.75

[Advances in elective therapy of kidney diseases]. Ther Ggw (1967) 0.75

[Preventive aspects of kidney diseases]. Dtsch Med J (1969) 0.75

Vascular lesions in human allotransplantated kidneys. Virchows Arch A Pathol Pathol Anat (1970) 0.75

Two cases of renal disease with unusual disturbances in calcium metabolism. Isr J Med Sci (1969) 0.75

Stress-induced changes of the venous circulation. Contrib Nephrol (1982) 0.75

Hypertension and renal parenchymal disease: mechanisms and management. Cardiovasc Clin (1978) 0.75

[Medical impressions from a trip to Australia and New Zealand]. Cas Lek Cesk (1968) 0.75

Mechanisms and recent advances in therapy of hypertension. Introduction. From Prague to Hannover. Contrib Nephrol (1977) 0.75

[Diuretic therapy]. ZFA (Stuttgart) (1982) 0.75

The effect of intravenous angiotensin II on the peripheral circulation with particular reference to its bearing on general haemodynamics. Clin Sci Mol Med Suppl (1976) 0.75

[Factors affecting long term prognosis of patients with chronic pyelonephritis]. Vnitr Lek (1968) 0.75

Treatment of pyelonephritis. Ger Med (1973) 0.75

[Chronic pyelonephritis]. Rev Med Liege (1969) 0.75

[Chronic pyelonephritis]. Z Gesamte Inn Med (1965) 0.75

[Behavior of peripheral blood circulation values in hypertension following diazoxide administration]. Verh Dtsch Ges Inn Med (1975) 0.75

[Hemodynamic basis of hypertension in non-uremic kidney patients. Conclusions which can be drawn with respect to the pathogenesis of hypertension in general]. Bull Mem Acad R Med Belg (1982) 0.75

[Measurement of renal venous blood flow in man, using the local thermodilution technic]. Cas Lek Cesk (1970) 0.75

Membranoproliferative glomerulonephritis in a patient with multiple myeloma and phenol intoxication. Przegl Lek (1985) 0.75

[A rational nephrological examination]. Vnitr Lek (1966) 0.75

[Disturbances of Free Water and Electrolyte Metabolism: Three large groups are differentiated]. MMW Munch Med Wochenschr (1976) 0.75

[Psychologic factors in arterial hypertension]. Lyon Med (1967) 0.75

[Histology and ultrastructure of biopsies from allotransplanted kidneys]. Beitr Pathol Anat (1969) 0.75